ELAHERE

Serial Number 90488884
Registration 7001216
700

Registration Progress

Application Filed
Jan 26, 2021
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered
Mar 14, 2023

Trademark Image

ELAHERE

Basic Information

Serial Number
90488884
Registration Number
7001216
Filing Date
January 26, 2021
Registration Date
March 14, 2023
Published for Opposition
March 22, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 14, 2023
Registration
Registered
Classes
005

Rights Holder

ImmunoGen, Inc.

03
Address
830 Winter Street
Waltham, MA 02451

Ownership History

ImmunoGen, Inc.

Original Applicant
03
Waltham, MA

ImmunoGen, Inc.

Owner at Publication
03
Waltham, MA

ImmunoGen, Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Jenevieve Maerker

USPTO Deadlines

Next Deadline
1321 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-03-14)
Due Date
March 14, 2029
Grace Period Ends
September 14, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Apr 26, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 14, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 14, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 7, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 6, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 9, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 9, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 8, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 8, 2022 IUAF S USE AMENDMENT FILED Loading...
Nov 8, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 4, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 4, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 4, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 17, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 16, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 15, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 15, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 16, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 16, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 12, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 29, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer, namely, antibody-drug conjugates; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
First Use Anywhere: Nov 22, 2022
First Use in Commerce: Nov 22, 2022

Classification

International Classes
005